Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00021723
Status:
TERMINATED
Last Update Posted:
2009-09-24
First Post:
2001-08-02
Brief Title:
Randomized Safety Tolerability and Pilot Efficacy of AN-1792 in Alzheimers Disease
Sponsor:
JANSSEN Alzheimer Immunotherapy Research Development LLC
Organization:
JANSSEN Alzheimer Immunotherapy Research Development LLC
Organization Data
Organization:
JANSSEN Alzheimer Immunotherapy Research Development LLC
Class:
INDUSTRY
Study ID:
AN-1792-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
JANSSEN Alzheimer Immunotherapy Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
VP Clinical Development
Old Organization:
JANSSEN Alzheimer Immunotherapy Research Development LLC
Collaborators
| Name | Class |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | INDUSTRY |